Clinical and epidemiological aspects of cardiomyopathies: A critical review of current knowledge

European Journal of Internal Medicine

Volumn 14, Issue 1, 2003, Pages 5-17

  Sangiorgi, Mario ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE   (Italy)

Author keywords

Arrhythmogenic CM; Cardiomyopathy; Dilated CM; Hypertrophic CM; Primary idiopathic CM; Restrictive CM; Secondary specific CM

Indexed keywords

MYOSIN; MYOSIN BINDING PROTEIN C; TROPOMYOSIN; TROPONIN I; TROPONIN T;

ARRHYTHMOGENESIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROCARDIOGRAPHY; GENE MUTATION; HEART ARRHYTHMIA; HEART DILATATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LONG QT SYNDROME; PATHOPHYSIOLOGY; PHENOTYPE; PROGNOSIS; RESTRICTIVE CARDIOMYOPATHY; REVIEW; RISK FACTOR; SUDDEN DEATH;

EID: 0037303411     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00215-7     Document Type: Review

References (115)

1. Report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Br Heart J. 44:1980;672-673.
2. Report of the 1995 WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Circulation. 93:1996;841-842.
3. Boffa G.M., Thiene G.A., Dalla Volta S. Cardiomyopathy: a necessary revision of the WHO classification. Int J Cardiol. 30:1991;1-7.
4. Sangiorgi M. Luci e ombre nella nuova classificazione delle cardiomiopatie. G Ital Cardiol. 26:1997;613-620.
5. Giles T.D. New WHO/ISFC classification of cardiomyopathies: a task not completed. Circulation. 96:1997;2081-2082.
6. Boffa G.M., Tarantini C., Abbasciano A., et al. Ischemic cardiomyopathy: lack of clinical applicability of the WHO/ISFC classification of cardiomyopathies. Ital Heart J. 2:(10):2001;778-781.
7. Brigden W. Uncommon myocardial disease: the non coronary cardiomyopathies. Lancet 1957; ii:1179-1184, 1243-1249.
8. Goodwin J.F., Oakley C.M. The cardiomyopathies. Br Heart J. 34:1972;545-552.
9. Seidman C.E., Seidman J.G. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol. 93:(Suppl 3):1998;13-16.
10. Schwartz M.L., Coxs G.F., Lin A.E., Korson M.S., et al. Clinical approach to genetic cardiomyopathy in children. Circulation. 94:1996;2021-2035.
11. Arbustini E. Counseling genetico nelle cardiomiopatie. G Ital Cardiol. 29:1999;505-513.
12. Neer E.J., Clapham D.E. Signal trasduction through G-proteins in the cardiac myocite. Trends Cardiovasc Med. 2:1992;6-11.
13. Priori S.G., Napolitano C., Schwartz P.J. Cardiac receptors activation and arrhythmogenesis. Eur Heart J. 14:(Suppl E):1993;20-26.
14. Farfel Z., Bourne H.R., Iiri T. The expanding spectrum of G protein diseases. N Engl J Med. 340:1999;1010-1020.
15. Di Mauro S., Wallace D.C. Mitochondrial DNA in human pathology. 1993;Raven Press, New York.
16. Towbin J.A., Vatta M. Molecular biology and the prolonged QT syndromes. Am J Med. 110:2001;385-398.
17. Hasenfuss G. Animal models of human cardiovascular desease, heart failure and hypertrophy. Review. Cardiovasc Res. 39:1998;60-76.
18. Davies C.H., Harding S.E., Poole-Wilson P.A. Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J. 17:1996;189-198.
19. Chien K.R. Stress pathways and heart failure. Cell. 98:1999;555-558.
20. Fontaine B. Les maladies des canaux ioniques. Rev Méd Interne. 20:1999;774-780.
21. Martin J.B. Molecular basis of the neurodegenerative disorders. N Engl J Med. 340:1999;1970-1980.
22. Fontaine G.H., Fontaliran F., Frank R. Arrythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses. Circulation. 97:1998;1532-1535.
23. Sangiorgi M. Myocardiopathies of unknown origin (primary cardomyopathies). Proceedings of the 14th International Congress of Internal Medicine. Excerpta Med Congress Series. 50:1978;22-33.
24. Sangiorgi M. Dilated and arrhythmogenous cardiomyopathies: old and new concepts. Cardiologia. 35:1990;967-976.
25. Sekiguchi M., Hasumi M., Hiroe M., et al. On the existence of non-hypertrophic, non-dilated cardiomyopathy as assessed by endomyocardial biopsy and a proposal for the term "electric disturbance type of cardiomyopathy" Circulation. 72:(Suppl III):1985;156.
26. Abelmann W.H., Lorell B.H. The challenge of cardiomyopathy. J Am Coll Cardiol. 13:1989;1219-1239.
27. Wynne J., Braunwald E. The cardiomyopathies and myocarditides. Braunwald E. Heart disease. Textbook of cardiovascular medicine. 5th edition: 1997;WB Saunders, Philadelphia.
28. Antozzi C., Zeviani M. Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc Res. 35:1997;184-199.
29. Bonnet D., De Lonlay P., Gautier I., et al. Efficiency of metabolic screening in children cardiomyopathies. Eur Heart J. 19:1998;790-793.
30. Lewis A.B. Is it time to retire 'idiopathic' cardiomyopathy? Eur Heart J. 19:1998;682-683.
31. Gavazzi A., De Maria R., Porcu M., et al. Cardiomiopatia dilatativa: una nuova storia naturale? L'esperienza dello Studio Policentrico Italiano Cardiomiopatie (SPIC). G Ital Cardiol. 25:1995;1109-1125.
32. Keren A., Gottlieb S., Tzivoni D., et al. Mildly dilated congestive cardiomyopathy. Use of prospectic diagnostic criteria and description of the clinical course without heart transplantation. Circulation. 81:1990;506-517.
33. Fuster V., Gersh B.J., Giuliani E.R., et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 47:1981;525-531.
34. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (two parts). N Engl J Med 1982;307:1051-1058, 1119-1126.
35. Diaz R.A., Obasohan A., Oakley C.M. Prediction of outcome in dilated cardiomyopathy. Br Heart J. 58:1987;393-399.
36. Forleo C., De Luca V., Guida P., Romito R., et al. Forme aritmiche e non aritmiche delle cardiomiopatie dilatative. Cardiologia. 44:1999;45.
37. Kuhn H., Breithardt G., Knierem H.J., et al. Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med J. 54:1978;451-459.
38. Baig M.K., Goldman J.H., Caforio A.L.P., et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol. 31:1998;195-201.
39. Guide Lines For The Study of Familial Dilated Cardiomyopathies. Eur Heart J. 20:1999;93-102.
40. Di Lenarda A., Hlede S., Sabbadini G., Davanzo M., et al. (Gruppo di studio sulle malattie del muscolo cardiaco). Il miglioramento della prognosi nella cardiomiopatia dilatativa idiopatica: il ruolo della diagnosi precoce e della terapia medica ottimizzata. G Ital Cardiol. 29:1999;1452-1462.
41. Michels V.V., Tazelaar H.D., Driscoll D.J., et al. Histopathology of familial vs. non-familial dilated cardiomyopathy. Cardiovasc Pathol. 2:1993;219-223.
42. Frustaci A., Pieroni M., Chimenti C. The role of endomyocardial biopsy in the diagnosis of cardiomyopathies. Ital Heart J. 3:(6):2002;348-353.
43. Demakis J.G., Rahimtoola S.H. Peripartum cardiomyopathy. Circulation. 44:1971;964-969.
44. Uhl U.S.M. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull John Hopkins Hosp. 91:1952;197-205.
45. Chin T.K., Perloff J.K., Williams R.G., et al. Isolated non compaction of the left ventricular myocardium: a study of eight cases. Circulation. 82:1990;507-513.
46. Martino T.A., Liu P., Sole M.J. Enterovirus myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. Rotbart H.A. Human enterovirus infections. 1995;291-350 Medical Society for Microbiology, Washington, DC.
47. Caforio A.L.P., Goodwin J.F. Aspetti attuali della patogenesi e del trattamento della cardiomiopatia dilatativa. Primary Cardiol. 8:1993;77-83.
48. Badorff C., Lee S.H., Lee G.H., et al. Disruption of the dystrophin-glycoprotein complex in human enteroviral cardiomyopathy. Circulation. 102:2000;3889.
49. Neuman D.A. Autoimmunity and dilated cardiomyopathy. Mayo Clin Proc. 69:1994;193-195.
50. Caforio A.L.P., Grazzini M., Mann J.M., et al. Identification of the alpha and beta myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 85:1992;1734-1742.
51. Limas C.J., Limas C.H.L.A. Antigens in idiopathic dilated cardiomyopathy. Am J Cardiol. 62:1989;379-383.
52. Di Nardo P., Minieri M., Lauro R., Kandolf R. Biologia molecolare delle cardiopatie virali. Cardiologia. 43:1998;1315-1321.
53. Fragola P.V., Autore C., Picelli A., et al. Familial idiopathic dilated cardiomyopathy. Am Heart J. 115:1988;912-914.
54. Michels V.V., Moll P.P., Miller F.A., et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 326:1992;77-82.
55. Towbin J.A., Hejtmancik F., Brink P., et al. X-linked cardiomyopathy (XLCM): molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophyn) gene at the Xp21 locus. Circulation. 887:1993;1854-1855.
56. Muntoni F., Cau M., Ganau A., et al. Brief report. Deletion of the dystrophin promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 329:1993;921-925.
57. Arbustini E., Diegoli M., Morbini P., Del Bello B., et al. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. JACC. 35:2000;1760-1768.
58. Grunig E., Tasman J.A., Kucherer H., Franz W., et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol. 31:1998;186-194.
59. Sinagra G., Di Lenarda A., Prodsky G.L., Taylor R.G., Muntoni F., et al. New insights into the molecular basis of familial dilated cardiomyopathy. Ital Heart J. 2:2001;280-286.
60. Olson T.M., Michels V.V., Thibodeau S.N., et al. Actin mutation in dilated cardiomyopathy, a heritable form of heart failure. Science. 280:1998;750-752.
61. Thoubin J.A., Boules K.R., Boules N.E. Etiologies of cardiomyopathy and heart failure. Nat Med. 5:1999;266-267.
62. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 341:1999;1276-1283.
63. Kamisago M., Sharma S.D., Depalma S.R., Solomon S., et al. Mutation in sarcomere protein genes as cause of dilated cardiomyopathy. N Engl J Med. 343:2000;1688-1696.
64. Zeviani M., Tiranti V., Piantadosi C. Mitocondrial disorders. Medicine. 77:1998;59-72.
65. Casali C., Santorelli F.M., D'Amati G., et al. A novel mt DNA mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun. 213:1995;588-593.
66. Duboc G, Becane HM, Bonne G, Varnous S et al. High incidence of sudden death in mycordial desease due to a lamin A/C gene mutation. Eur Heart J 1999; 20 (Abstract Supplement XXIst Congress of the ESC).
67. Fatkin D., MacRae C., Takeshi S., Wolff M.R., et al. Missense mutations in the road domain of the lamin A/C gene as causes of dilated cardiomyiopathy and conduction system disease. N Engl J Med. 341:1999;1715-1724.
68. Kass S., MacRae C., Graber H.L., et al. A gene defect that causes conduction system desease and dilated cardiomyopathy maps to chromosome 1p-1q1. Nat Genet. 7:1994;546-551.
69. Thierfelder L., MacRae C., Watkins H., et al. Familial cardiomyopathy is a disease of the sarcomere. Circulation. 90:(Suppl I):1994;1-519.
70. Michele D.E., Metger J.M. Contractil dysfunction in hypertrophic cardiomyopathy elucidating primary defects of mutant contractile proteins by gene transfer. Trends Cardiovasc Med. 10:2000;177-182.
71. Marian A.J., Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 92:1995;1336-1347.
72. Marian A.J., Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol. 9:1998;88-99.
73. MacRae C., Ghaisas N., Kass S.S., et al. Familiar hypertrophic cardiomyopathy with Wolff-Parkinson-White maps to a locus on chromosome 7q3. J Clin Invest. 96:1995;1216-1220.
74. Arbustini E., Fasani R., Morbini P., et al. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart. 80:1998;848-858.
75. Straceski A.J., Geisterfer-Lowrance A., Seidman C.E., et al. Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 91:1994;589-593.
76. Lankford E.B., Epstein N.D., Fananazapir L., Sweeney L. Abnormal conctractil properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest. 95:1995;1409-1414.
77. Maron B.J., Shirani J., Poliac L.C., et al. Sudden death in young competitive athetes. Clinical, demographic and pathological profiles. J Am Med Assoc. 276:1996;199-204.
78. Virmani R., Burke A.P., Farb A., Kark J.A. Causes of sudden death in young and middle-aged competitive athletes. Cardiol Clin. 15:1997;439-466.
79. Hengstenberg C., Maisch B. Increased nuclear proto-oncogene expression in hypertrophic cardiomyopathy. Cardioscience. 4:1993;15-20.
80. Lechin M., Yu Q.T., Workman R., et al. Angiotensine converting enzyme genotype DD is associated with increased letf ventricular mass in patience with hypertrophic cardiomyopathy (Abstract). Circulation. 90:(Suppl 1):1994;1-174.
81. Wigle E.D., Rakowski H., Kimball B.P., Williams W.G. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 92:1995;1680-1692.
82. Maron B.J., Gottdiener J.S., Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 48:1981;418-428.
83. Pavel G., Widimsky P., Cervenka V., et al. Electrocardiographic changes can precede the development of myocardial hypertrophy in the setting of hypertrophic cardiomyopathy. Int J Cardiol. 23:1989;335-341.
84. Rapezzi C., Coccolo F., Amati S., et al. Cardiomiopatia ipertrofica: forme comuni e forme rare. Cardiologia. 41:(Suppl 4):1996;691-699.
85. Sangiorgi M., Giuliano D., Auriti R. Cardiomiopatia ipertrofica con stenosi infundibulare dinamica isolata del ventricolo destro. Cardiol Prat. 27:1976;7-15.
86. Hosenpud J.D., Niles N.R. Clinical hemodynamic and endomyocardial biopsy findings in idiopathic restrictive cardiomyopathy. West J Med. 144:1986;303-306.
87. Bosman C., Zachara E., Boldrini R. Cardiomiopatie dilatative e restrittive. Aspetti morfologici. G Ital Cardiol. 29:1999;1177-1180.
88. Davies J.N.P. African endomyocardial fibrosis. Cardiovasc Clin. 4:1972;275-280.
89. Löffler W. Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz Med Wschr. 66:1936;817-820.
90. Stoeckel M.E., Osborn M., Porte A., et al. An unusual familial cardiomyopathy characterized by aberrant accumulation of desmin-type intermediate filaments. Virchow's Arch. 393:1981;53-60.
91. Zachara E., Bertini E., Lioy E., et al. Restrictive cardiomyopathy due to desmin accumulation in a family with evidence of autosomal dominant inheritance. G Ital Cardiol. 27:1997;436-442.
92. McKinney B. Pathology of the cardiomyopathies. 1974;Butterworth, London.
93. Edwards W.D. Transvenous endomyocardial biopsy. Unexplained arrhythmias. Giuliani E.R. Mayo practice of cardiology. 3rd edition: 1996;679 Publisher Mosby, Saint Louis.
94. Sugrue D.D., Holmes D.R., Gersh B.J., et al. Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol. 4:1984;952-957.
95. Vignola P.A., Aonuma K., Swaye P.S., et al. Lymphocitic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression. J Am Coll Cardiol. 4:1984;812-819.
96. Kennedy H.L., Pescarmona J.E., Bouchard R.J., et al. Objective evidence of occult myocardial dysfunction in patients with frequent ventricular ectopy without clinically apparent heart disease. Am Heart J. 104:1982;57-65.
97. Corrado D., Basso C., Thiene G. Substrato anatomo-patologico dell'ipereccitabilità ventricolare in cuore apparentemente sano. G Ital Cardiol. 41:(Suppl 4):1996;457-460.
98. Carlson M.D., White R.D., Trohman R.G., et al. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using Cine Magnetic Resonance Imaging. J Am Coll Cardiol. 24:1994;720-727.
99. Fenici R.R., Melillo G., Masselli M. Clinical magnetocardiography: ten years experiences, in: Fenici RR: Biomagnetic imaging for ablation of cardiac arrhythmias. Int J Cardiac Imaging. 7:1991;151-167.
100. Marcus F.I., Fontaine G.H., Guiraudon G., et al. Right ventricular dysplasia: A report of 24 cases. Circulation. 65:1982;384-399.
101. Thiene G., Nava A., Corrado D., et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 318:1988;129-133.
102. Genetic and molecular basis of cardiac arrhythmias. Impact on clinical management. Eur Heart J. 20:1999;174-195.
103. Coonar A.S., Protonotarios N., Tsatsopoulou A., et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse non epidermolytic palmoplantar kerotoderma and woolly hair (Naxos disease) maps to chromosome 17q21. Circulation. 97:1998;2049-2058.
104. Brugada J., Brugada R. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 20:1992;1391-1396.
105. Martini B., Nava A., Thiene G., et al. Ventricular fibrillation without apparent heart disease: description of 6 cases. Am Heart J. 118:1989;1203-1209.
106. Nademanee K. Sudden unexplained death syndrome in Southeast Asia. Am J Cardiol. 79:(6A):1997;10-11.
107. Cerrone M., Crotti L., Faggiano G., De Michelis V., et al. Sindrome del QT lungo e sindrome di Brugada: due aspetti della stessa malattia? Ital Heart J (Suppl). 2:2001;253-257.
108. Gaita F., Giustetto C., Leclercq J.F., et al. Idiopathic verapamil-responsive left ventricular tachycardia: clinical characteristics and long-term follow-up of 33 patients. Eur Heart J. 15:1994;1252-1260.
109. Naccarella F., Palmieri M., Accorsi A., et al. Benign long term prognosis of frequent and complex ventricular arrhythmias (NSVT) in apparently healthy subjects but evidence over time of silent underlying cardiac disease. Int J Amb Monit. 7:1994;170-172.
110. James T.N. Myocarditis and cardiomyopathy: the panoramic nature of their etiology, pathogenesis and clinical consequences with special consideration of the involvement of the conduction system. Just H., Schuster H.P. Myocarditis and cardiomyopathy. 1983;25-62 Springer Verlag, Berlin.
111. James T.N. Normal variations and pathologic changes in structure of the cardiac conduction system and their functional significance. J Am Coll Cardiol. 5:(Suppl):1985;B71-B78.
112. Sarachek N.S., Leonard J.J. Familial heart block and sinus bradicardia. Classification and natural history. Am J Cardiol. 29:1972;451-458.
113. Sekiguchi M., Hiroe M., Kasamuki H., et al. Experience of 100 atrial endomyocardial biopsies and the concept of atrial cardiomyopathy. Circulation. 70:(Suppl II):1984;118.
114. Kopecky S.L., Gersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 317:1987;669-677.
115. Lehman H., Klein E. Familias sinus node dysfonction with autosomal dominant inheritance. Br Heart J. 40:1978;1314-1316.